Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute lymphoblastic leukemia in childhood.

D G Poplack

    Pediatric Clinics of North America
    |June 1, 1985
    PubMed
    Summary

    This review covers past progress, current biologic and therapeutic strategies, and future challenges in treating acute lymphoblastic leukemia (ALL). Understanding these factors is key to advancing ALL treatment outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Capacity building: a novel pediatric hematology-oncology fellowship program in sub-Saharan Africa.

    Blood advances·2018
    Same author

    Neoplastic meningitis: diagnosis and treatment considerations.

    Medical oncology (Northwood, London, England)·2000
    Same author

    Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration.

    Cancer chemotherapy and pharmacology·2000
    Same author

    2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition.

    Drug metabolism and disposition: the biological fate of chemicals·1999
    Same author

    Retinoblastoma treatment.

    Science (New York, N.Y.)·1999
    Same author

    Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.

    Journal of pediatric hematology/oncology·1999

    Area of Science:

    • Hematology
    • Oncology

    Background:

    • Acute lymphoblastic leukemia (ALL) remains a significant hematologic malignancy.
    • Progress in ALL treatment has been driven by various factors over time.

    Purpose of the Study:

    • To review historical factors contributing to ALL treatment advancements.
    • To describe current biologic and therapeutic strategies for ALL.
    • To identify unresolved issues and future challenges in ALL therapy.

    Main Methods:

    • Literature review of past and present ALL research.
    • Analysis of current biologic agents and therapeutic modalities.
    • Discussion of ongoing clinical trials and future research directions.

    Main Results:

    • Past progress in ALL treatment is attributed to advancements in chemotherapy, stem cell transplantation, and targeted therapies.
    • Current approaches involve risk-stratified treatment protocols, novel immunotherapies, and molecularly targeted drugs.
    • Significant challenges remain, including refractory disease, treatment toxicity, and long-term survivorship.

    Conclusions:

    • Continued progress in ALL requires a comprehensive understanding of its biology and the evolution of treatment strategies.
    • Addressing unmet needs in ALL necessitates innovative therapeutic development and personalized medicine.
    • Future research should focus on overcoming treatment resistance and improving quality of life for ALL patients.

    Related Experiment Videos